{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:20:15Z","timestamp":1794583215575,"version":"4.9.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.drugalcdep.2014.03.006","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T19:31:32Z","timestamp":1395257492000},"page":"79-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["The impact of buprenorphine\/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients"],"prefix":"10.1016","volume":"139","author":[{"given":"E. Jennifer","family":"Edelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtan","family":"Chantarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn E.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.03.006_bib0005","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","article-title":"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study","volume":"56","author":"Altice","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2307\/3001775","article-title":"Tests for linear trends in proportions and frequencies","volume":"11","author":"Armitage","year":"1955","journal-title":"Biometrics"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0020","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","article-title":"The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations","volume":"51","author":"Baron","year":"1986","journal-title":"J. Pers. Soc. Psychol."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0025","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/sim.2619","article-title":"Robustness of a multivariate normal approximation for imputation of incomplete binary data","volume":"26","author":"Bernaards","year":"2007","journal-title":"Stat. Med."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0030","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.addbeh.2004.01.006","article-title":"Drug injection cessation among HIV-infected injecting drug users","volume":"29","author":"Bouhnik","year":"2004","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0035","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/01.ALC.0000171937.87731.28","article-title":"A temporal and dose\u2013response association between alcohol consumption and medication adherence among veterans in care","volume":"29","author":"Braithwaite","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1751-0473-3-17","article-title":"Purposeful selection of variables in logistic regression","volume":"3","author":"Bursac","year":"2008","journal-title":"Source Code Biol. Med."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1360-0443.2009.02812.x","article-title":"Reducing sex under the influence of drugs or alcohol for patients in substance abuse treatment","volume":"105","author":"Calsyn","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jsat.2008.11.008","article-title":"Motivational and skills training HIV\/sexually transmitted infection sexual risk reduction groups for men","volume":"37","author":"Calsyn","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0055","series-title":"Task Force on HIV\/AIDS. Combating the Twin Epidemics of the HIV\/AIDS and Drug Addiction: Opportunities for Progress and Gaps in Scale","author":"Center for Strategic and Internationa Studies (CSIS)","year":"2008"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0060","series-title":"Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction: Treatment Imprvement Protocol (TIP) Series 40","author":"Center for Substance Abuse Treatment","year":"2004"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.03.006_bib0065","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/QAI.0b013e318209d3b9","article-title":"Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine\/naloxone and HIV care","volume":"56","author":"Chaudhry","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2307\/3001616","article-title":"Some methods for strengthening the common \u03c72 tests","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0075","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1007\/s10461-013-0539-4","article-title":"A randomized controlled trial of the Community-friendly Health Recovery Program (CHRP) among high-risk drug users in treatment","volume":"17","author":"Copenhaver","year":"2013","journal-title":"AIDS Behav."},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2014.03.006_bib0080","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1097\/QAI.0b013e3181fbca5a","article-title":"Progress in HIV reduction and prevention among injection and noninjection drug users","volume":"55","author":"Crawford","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.STR.30.1.34","article-title":"Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke","volume":"30","author":"Demchuk","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0090","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1017\/S0033291700048017","article-title":"The brief symptom inventory: an introductory report","volume":"13","author":"Derogatis","year":"1983","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QAD.0b013e3280114a15","article-title":"Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City","volume":"21","author":"Des Jarlais","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/ADM.0b013e3182a3b603","article-title":"HIV testing and sexual risk reduction counseling in office-based buprenorphine\/naloxone treatment","volume":"7","author":"Edelman","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10461-009-9625-z","article-title":"Age and HIV sexual risk among women in methadone treatment","volume":"15","author":"Engstrom","year":"2011","journal-title":"AIDS Behav."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.03.006_bib0110","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/QAI.0b013e3182097537","article-title":"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine\/naloxone","volume":"56","author":"Fiellin","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0115","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1097\/QAD.0b013e32835ad438","article-title":"Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users","volume":"26","author":"Fu","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0120","first-page":"CD004145","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","author":"Gowing","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1207\/S15324796ABM2403_08","article-title":"Sensation seeking and alcohol use as markers of sexual transmission risk behavior in HIV-positive men","volume":"24","author":"Kalichman","year":"2002","journal-title":"Ann. Behav. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.03.006_bib0130","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.drugalcdep.2007.01.004","article-title":"Correlates of consistent condom use with main partners by partnership patterns among young adult male injection drug users from five US cities","volume":"91","author":"Kapadia","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0135","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s10461-009-9569-3","article-title":"Longitudinal determinants of consistent condom use by partner type among young injection drug users: the role of personal and partner characteristics","volume":"15","author":"Kapadia","year":"2011","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QAI.0b013e31818a652c","article-title":"Housing status and HIV risk behaviors among homeless and housed persons with HIV","volume":"49","author":"Kidder","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.03.006_bib0145","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/QAI.0b013e318209754c","article-title":"Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics","volume":"56","author":"Korthuis","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0150","doi-asserted-by":"crossref","first-page":"e5945","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.03.006_bib0155","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/QAI.0b013e3181f9c203","article-title":"Toward a comprehensive approach to HIV prevention for people who use drugs","volume":"55","author":"Marshall","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0160","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage","volume":"375","author":"Mathers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0165","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0170","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/02791072.2012.703507","article-title":"Sexual HIV risk behaviors in a treatment-refractory opioid-dependent sample","volume":"44","author":"McHugh","year":"2012","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0180","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005053-198507000-00005","article-title":"New data from the addiction severity index: reliability and validity in three centers","volume":"173","author":"McLellan","year":"1985","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0185","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hup.2339","article-title":"Longitudinal missing data strategies for substance use clinical trials using generalized estimating equations: an example with a buprenorphine trial","volume":"28","author":"McPherson","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0190","first-page":"1049","article-title":"Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up","volume":"6","author":"Metzger","year":"1993","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","article-title":"The impact of confounder selection criteria on effect estimation","volume":"129","author":"Mickey","year":"1989","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0200","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/01621459.1996.10476908","article-title":"Multiple imputation after 18+ years","volume":"91","author":"Rubin","year":"1996","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0205","series-title":"Longitudinal Data Analysis with Discrete and Continuous Responses Course Note","author":"SAS Institute Inc","year":"2009"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1023\/B:AIBE.0000004730.62934.ed","article-title":"Predictors of HIV sexual risk behaviors in a community sample of injection drug-using men and women","volume":"7","author":"Somlai","year":"2003","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11904-010-0043-7","article-title":"Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions","volume":"7","author":"Strathdee","year":"2010","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0220","doi-asserted-by":"crossref","first-page":"662","DOI":"10.7326\/0003-4819-148-9-200805060-00006","article-title":"Narrative review: buprenorphine for opioid-dependent patients in office practice","volume":"148","author":"Sullivan","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0225","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jsat.2007.08.004","article-title":"Buprenorphine\/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors","volume":"35","author":"Sullivan","year":"2008","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0230","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/ADM.0b013e31827f9bdf","article-title":"Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment","volume":"7","author":"Tetrault","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0235","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10461-006-9159-6","article-title":"Alcohol consumption, ART usage and high-risk sex among women infected with HIV","volume":"11","author":"Theall","year":"2007","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0240","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.drugalcdep.2013.01.009","article-title":"Is cannabis use associated with HIV drug and sex risk behaviors among Russian HIV-infected risky drinkers?","volume":"132","author":"Tyurina","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0245","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jana.2009.07.008","article-title":"Relationships between stigma, social support, and depression in HIV-infected African American women living in the rural Southeastern United States","volume":"21","author":"Vyavaharkar","year":"2010","journal-title":"J. Assoc. Nurses AIDS Care"},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0250","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s10461-007-9243-6","article-title":"Implications of cannabis use and heavy alcohol use on HIV drug risk behaviors in Russian heroin users","volume":"12","author":"Walley","year":"2008","journal-title":"AIDS Behav."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.03.006_bib0255","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/QAI.0b013e3182097426","article-title":"The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine\/naloxone and HIV treatment","volume":"56","author":"Weiss","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2014.03.006_bib0260","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1758-2652-15-10","article-title":"Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers","volume":"15","author":"Westergaard","year":"2012","journal-title":"J. Int. AIDS Soc."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614007820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614007820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T17:20:31Z","timestamp":1565284831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614007820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":52,"alternative-id":["S0376871614007820"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.03.006","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of buprenorphine\/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}